Impaired Osteoblastogenesis in a Murine Model of Dominant Osteogenesis Imperfecta: A New Target for Osteogenesis Imperfecta Pharmacological Therapy

The molecular basis underlying the clinical phenotype in bone diseases is customarily associated with abnormal extracellular matrix structure and/or properties. More recently, cellular malfunction has been identified as a concomitant causative factor and increased attention has focused on stem cells...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gioia, Roberta, Panaroni, Cristina, Besio, Roberta, Palladini, Giovanni, Merlini, Giampaolo, Giansanti, Vincenzo, Scovassi, Ivana A., Villani, Simona, Villa, Isabella, Villa, Anna, Vezzoni, Paolo, Tenni, Ruggero, Rossi, Antonio, Marini, Joan C., Forlino, Antonella
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3459187/
https://ncbi.nlm.nih.gov/pubmed/22511244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.1107
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים